Navio MD review
Brand beside compounded
Compounded tirzepatide from $189 a month sits on the same menu as a branded tirzepatide line from $445 — one molecule, two supply routes, both tiered by dose.
Our verdict
Navio MD does something most of this category avoids: it carries the branded product and the compounded version of the same molecule together, and publishes a figure for each. Compounded tirzepatide opens at $189 a month against $445 for the branded line, a $256 gap on the same active drug. Brand Ozempic opens at $345. All three figures are the bottom rung of a dose ladder, so the opening price is the one a titrating buyer leaves behind soonest.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- States
- 48
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 48 states
- Updated
- September 2026
What it is
A 48-state telehealth seller carrying branded GLP-1 products alongside a compounded tirzepatide line, with each product priced on its own dose-indexed scale.
How it works
Prescription-gated telehealth in which the prescribed strength sets the price. Both supply routes appear on the same menu, so choosing between them is a price decision rather than a separate product search.
Pricing transparency
Compounded tirzepatide starts at $189 a month and is tiered by dose. Brand Ozempic starts at $345, again varying by dose. A branded tirzepatide line starts at $445 on the same tiered basis. Navio MD publishes the floor of each ladder and not the rungs above it, so the top of every scale is unstated.
Branded vs compounded
Branded GLP-1 products and a compounded tirzepatide preparation, sold side by side. The branded lines are FDA-approved drugs. The compounded tirzepatide is not: compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- Brand and compounded priced on one menu
- A $256 monthly gap between the two tirzepatide routes
- Dose tiering is disclosed rather than discovered later
- 48 states
Watch-outs
- Only the floor of each dose ladder is published
- $189 is an entry rung, not a maintenance rate
- Branded tirzepatide at $445 is at the expensive end
- Compounding pharmacy is not named
Best for
Buyers weighing brand against compounded without leaving one menu.
Who should look elsewhere
Anyone who needs a maintenance-dose figure before starting.
How Navio MD compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A discounted rate, if it lasts
See SkinnyRx → - Bodybuilding Health+
A headline that is the month-to-month rate
See Bodybuilding Health+ → - Oak
Flat dose pricing without a subscription
See Oak →
More GLP-1 telehealth sellers reviews: MyFastRxNEUVÉ HealthNextMedsNoBsRxNoluNouri
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of Navio MD’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does Navio MD charge for tirzepatide?
- $189 a month at the entry dose for the compounded version, and $445 for the branded line. Both are the bottom rung of a dose ladder, so a buyer who titrates upward pays more than either. At the floor the two routes stand $256 apart.
- Is the branded product worth $256 more a month?
- That is the trade this menu puts in front of a buyer. The branded tirzepatide is an FDA-approved drug supplied by its manufacturer. The compounded version is prepared to order and carries no FDA review before it is dispensed. Across a year the difference at the opening doses is $3,072.
- How much is Ozempic here?
- From $345 a month, with the figure varying by dose. That buys the branded drug rather than a compounded substitute. What the higher strengths cost is not published.
- Does the price climb as the dose does?
- Yes, on all three lines. Each is described as tiered by dose, and only the starting figure appears anywhere. Semaglutide and tirzepatide both titrate upward over the early months, so budgeting against the opening rung understates a year.
- Is Navio MD legit?
- Navio MD is a GLP-1 telehealth sellers service. Its stated availability: 48 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Navio MD expensive compared with other GLP-1 telehealth sellers providers?
- Navio MD publishes a starting figure of $189/mo. Across the 115 GLP-1 telehealth sellers providers we review that publish a single monthly figure, those run $76 to $369 with a median of $170, which puts Navio MD above the median. The other 5 GLP-1 telehealth sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.